{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:44:45Z","timestamp":1789343085167,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.berh.2023.101893","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T05:06:06Z","timestamp":1700629566000},"page":"101893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Systemic lupus erythematosus and damage: What has changed over the past 20 years?"],"prefix":"10.1016","volume":"37","author":[{"given":"Carolina","family":"Mu\u00f1oz-Grajales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin Beste","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Svenungsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.berh.2023.101893_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2023.101893_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000448","article-title":"Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus","volume":"8","author":"Sivakumaran","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib5","first-page":"709","article-title":"The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study","volume":"56","author":"Hermansen","year":"2017","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2016-210973","article-title":"Stroke in systemic lupus erythematosus: a Swedish population-based cohort study","volume":"76","author":"Arkema","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study","volume":"69","author":"Avi\u00f1a-Zubieta","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2023.101893_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152226","article-title":"Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up","volume":"61","author":"Farina","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000398","article-title":"Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE","volume":"7","author":"Nived","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/acr2.1035","article-title":"Association of lupus nephritis with coronary artery disease by ISN\/RPS classification: results from a large real-world lupus population","volume":"1","author":"Sun","year":"2019","journal-title":"ACR open Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000590","article-title":"Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies","volume":"8","author":"Ugarte-Gil","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"8","key":"10.1016\/j.berh.2023.101893_bib12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kws130","article-title":"Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus","volume":"176","author":"Magder","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/annrheumdis-2020-219727","article-title":"Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus","volume":"80","author":"Reid","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174572","article-title":"Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: case control study of 281 SLE patients and 281 individually matched population controls","volume":"12","author":"Gustafsson","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.berh.2023.101893_bib15","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/rheumatology\/keaa092","article-title":"Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus","volume":"59","author":"Svenungsson","year":"2020","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.berh.2023.101893_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/art.41392","article-title":"Accrual of atherosclerotic vascular events in a multicenter inception systemic lupus erythematosus cohort","volume":"72","author":"Urowitz","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2023.101893_bib18","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar3759","article-title":"Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study","volume":"14","author":"Gustafsson","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib19","first-page":"602","article-title":"Framingham, ACC\/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?","volume":"38","author":"Di Battista","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000346","article-title":"Development of a systemic lupus erythematosus cardiovascular risk equation","volume":"6","author":"Petri","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2023.101893_bib21","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12518","article-title":"Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study","volume":"12","author":"Chung","year":"2014","journal-title":"J Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.berh.2023.101893_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2015.05.008","article-title":"The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: a general population-based study","volume":"45","author":"Avi\u00f1a-Zubieta","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2023.101893_bib24","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/art.21149","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients","volume":"52","author":"Calvo-Al\u00e9n","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib25","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40744-022-00513-1","article-title":"Systematic literature review and meta-analysis of venous thromboembolism events in systemic lupus erythematosus","volume":"10","author":"Bello","year":"2023","journal-title":"Rheumatol Ther"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099386","article-title":"Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus","volume":"9","author":"Lood","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.berh.2023.101893_bib28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2008.093013","article-title":"Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort","volume":"68","author":"Kaiser","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2023.101893_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/acr2.1030","article-title":"Systemic lupus erythematosus is associated with a high risk of venous thromboembolism in hospitalized patients leading to poor outcomes and a higher cost: results from nationwide inpatient sample database 2003-2011","volume":"1","author":"Kishore","year":"2019","journal-title":"ACR open Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2023.101893_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/jalm\/jfac036","article-title":"A review of lupus nephritis","volume":"7","author":"Alforaih","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"7","key":"10.1016\/j.berh.2023.101893_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203315627202","article-title":"Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2023.101893_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40744-023-00532-6","article-title":"Clinical and economic burden of systemic lupus erythematosus in the years preceding end-stage kidney disease diagnosis: a retrospective observational study","volume":"10","author":"Huang","year":"2023","journal-title":"Rheumatol Ther"},{"issue":"11","key":"10.1016\/j.berh.2023.101893_bib35","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"Anders","year":"2020","journal-title":"Lupus nephritis. Nat Rev Dis Prim."},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib38","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"Supplement_5","key":"10.1016\/j.berh.2023.101893_bib39","doi-asserted-by":"crossref","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3899\/jrheum.220345","article-title":"Renal histopathology associated with kidney failure and mortality in patients with lupus nephritis: a long-term real-world data study","volume":"50","author":"Liao","year":"2023","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib41","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/rheumatology\/kem016","article-title":"Treatment adherence and clinical outcome in systemic lupus erythematosus","volume":"46","author":"Chambers","year":"2007","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib42","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3899\/jrheum.191064","article-title":"Advanced chronic kidney disease in lupus nephritis: is dialysis inevitable?","volume":"47","author":"Tselios","year":"2020","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2023.101893_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3899\/jrheum.200566","article-title":"Lupus nephritis and chronic kidney disease","volume":"47","author":"Salama","year":"2020","journal-title":"J Rheumatol"},{"issue":"13","key":"10.1016\/j.berh.2023.101893_bib44","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0961203313505689","article-title":"The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort","volume":"22","author":"Lee","year":"2013","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/rheumatology\/kes391","article-title":"All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre","volume":"52","author":"Lee","year":"2013","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2023.101893_bib46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0961203313493032","article-title":"Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies","volume":"22","author":"Danza","year":"2013","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/rheumatology\/keaa478","article-title":"The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis","volume":"60","author":"Pego-Reigosa","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000510","article-title":"Infection hospitalisation in systemic lupus in Sweden","volume":"8","author":"Simard","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"7","key":"10.1016\/j.berh.2023.101893_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/1744666X.2019.1620601","article-title":"Metabolic syndrome and systemic lupus erythematosus: the connection","volume":"15","author":"Mok","year":"2019","journal-title":"Expet Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00296-015-3316-z","article-title":"Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age","volume":"36","author":"Medeiros","year":"2016","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.berh.2023.101893_bib51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/1756-185X.13153","article-title":"Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: a meta-analysis","volume":"20","author":"Sun","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000436","article-title":"Associations of metabolic syndrome in SLE","volume":"7","author":"Apostolopoulos","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0961203312462756","article-title":"Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus","volume":"22","author":"Ormseth","year":"2013","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11657-019-0667-1","article-title":"A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors","volume":"15","author":"Gu","year":"2020","journal-title":"Arch Osteoporosis"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib55","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/acr.22751","article-title":"Burden of comorbidity in systemic lupus erythematosus in the UK, 1999\u20132012","volume":"68","author":"Rees","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2023.101893_bib56","first-page":"1","article-title":"Prevalence and risk factors of reduced bone mineral density in systemic lupus erythematosus patients: a meta-analysis","volume":"2019","author":"Xia","year":"2019","journal-title":"BioMed Res Int"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196113","article-title":"Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: a systematic review and meta-regression","volume":"13","author":"Mendoza-Pinto","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/03009742.2013.775331","article-title":"Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus","volume":"42","author":"Ekblom-Kullberg","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib59","doi-asserted-by":"crossref","first-page":"R175","DOI":"10.1186\/ar3500","article-title":"Soluble receptor activator of nuclear factor \u03baB ligand\/osteoprotegerin ratio is increased in systemic lupus erythematosus patients","volume":"13","author":"Carmona-Fernandes","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.berh.2023.101893_bib60","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.3390\/ijms23105804","article-title":"Bone involvement in systemic lupus erythematosus","volume":"23","author":"Rella","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0961203316664597","article-title":"Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus","volume":"26","author":"Cramarossa","year":"2017","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib62","first-page":"700","article-title":"A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors","volume":"35","author":"Nevskaya","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2023.101893_bib63","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1177\/09612033211031007","article-title":"Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: prevalence, pattern, and comparison of natural course","volume":"30","author":"Ersin","year":"2021","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0961203313512880","article-title":"Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome","volume":"23","author":"Lee","year":"2014","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.berh.2023.101893_bib65","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/38.10.953","article-title":"Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation1","volume":"38","author":"Swaak","year":"1999","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2023.101893_bib66","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.60.12.1145","article-title":"Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment","volume":"60","author":"Oinuma","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib67","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(85)90057-9","article-title":"Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus","volume":"79","author":"Zizic","year":"1985","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.berh.2023.101893_bib68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Assouline-Dayan","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2023.101893_bib69","first-page":"11","article-title":"Glucocorticoid\u2010induced osteonecrosis in systemic lupus erythematosus patients","author":"Kaneko","year":"2021","journal-title":"Clin Transl Med"},{"issue":"7","key":"10.1016\/j.berh.2023.101893_bib70","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/acr.24541","article-title":"Predictors of osteonecrosis in systemic lupus erythematosus: a prospective cohort study","volume":"74","author":"Kallas","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13075-023-03061-3","article-title":"Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII","volume":"25","author":"Cheng","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.berh.2023.101893_bib72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it ? A systematic review and meta-analysis","volume":"48","author":"Rayes","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101893_bib73","series-title":"Neuropsychiatric involvement in systemic lupus erythematosus","author":"Hermosillo-romo","year":"2002"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib74","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib75","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.semarthrit.2021.05.018","article-title":"Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: a systematic review","volume":"51","author":"Yuen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2023.101893_bib76","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40744-021-00312-0","article-title":"Cognitive dysfunction in systemic lupus erythematosus: immunopathology, clinical manifestations, neuroimaging and management","volume":"8","author":"Seet","year":"2021","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.berh.2023.101893_bib77","series-title":"Factors influencing cognitive function , sleep , and quality of life in individuals with systemic lupus erythematosus : a review of the literature factors influencing cognitive function , sleep , and quality of life in individuals with systemic lupus eryt","first-page":"4046","author":"Sweet","year":"2010"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib78","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/art.24346","article-title":"Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study","volume":"61","author":"Appenzeller","year":"2009","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib79","first-page":"1038","article-title":"The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus","volume":"35","author":"Tam","year":"2008","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/03009742.2016.1206617","article-title":"Impact of cognitive impairment , depression , disease activity , and disease damage on quality of life in women with systemic lupus erythematosus","volume":"46","author":"Calder\u00f3n","year":"2017","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Nervous system disease in systemic lupus erythematosus: current status and future directions","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101893_bib82","doi-asserted-by":"crossref","unstructured":"Nantes SG, Su J, Dhaliwal A, Colosimo K, Touma Z. Performance of screening tests for cognitive impairment in systemic lupus erythematosus. (1):1583\u20131589.","DOI":"10.3899\/jrheum.161125"},{"key":"10.1016\/j.berh.2023.101893_bib83","article-title":"Cognitive function trajectories are associated with the depressive symptoms trajectories in systemic lupus erythematosus over time","author":"Touma","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2023.101893_bib84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/acr2.11529","article-title":"Intraindividual change in cognitive function among adults with systemic lupus erythematosus: a markov analysis over 7 years","volume":"5","author":"Perera","year":"2023","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib85","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.semarthrit.2021.09.008","article-title":"Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus","volume":"51","author":"Bingham","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib86","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.20692","article-title":"Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus","volume":"51","author":"Kozora","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib87","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib88","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semarthrit.2019.06.017","article-title":"Prevalence and metric of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"50","author":"Moustafa","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2023.101893_bib89","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/art.39111","article-title":"Mood disorders in systemic lupus erythematosus: results from an international inception cohort study","volume":"67","author":"Hanly","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2023.101893_bib90","first-page":"389","article-title":"Association of depressive\/anxiety symptoms with quality of life and work ability in patients with systemic lupus erythematosus","volume":"34","author":"Mok","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"28","key":"10.1016\/j.berh.2023.101893_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011376","article-title":"Depression and anxiety in systemic lupus erythematosus","volume":"97","author":"Figueiredo-Braga","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib92","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12888-022-04236-z","article-title":"A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus","volume":"22","author":"Liao","year":"2022","journal-title":"BMC Psychiatr"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/acr2.11205","article-title":"Exploring the mental health needs of persons with autoimmune diseases during the coronavirus disease 2019 pandemic: a proposed framework for future research and clinical care","volume":"3","author":"Bingham","year":"2021","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib94","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000291","article-title":"Alopecias in lupus erythematosus","volume":"5","author":"Concha","year":"2018","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3899\/jrheum.220089","article-title":"Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist","volume":"50","author":"Stull","year":"2023","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2023.101893_bib96","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/rheumatology\/keaa098","article-title":"Association between depression and anxiety with skin and musculoskeletal clinical phenotypes in systemic lupus erythematosus","volume":"59","author":"Eldeiry","year":"2020","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib97","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/0961203321995257","article-title":"Smoking exposure in pack-years predicts cutaneous manifestations and damage in systemic lupus erythematosus","volume":"30","author":"Ezeh","year":"2021","journal-title":"Lupus"},{"issue":"10094","key":"10.1016\/j.berh.2023.101893_bib98","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"Liu","year":"2017","journal-title":"Cataracts. Lancet."},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib99","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12886-020-01360-w","article-title":"Risks of ophthalmic disorders in patients with systemic lupus erythematosus \u2013 a secondary cohort analysis of population-based claims data","volume":"20","author":"Hsu","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.berh.2023.101893_bib100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00296-014-3129-5","article-title":"Risk factors for cataracts in systemic lupus erythematosus (SLE)","volume":"35","author":"Alderaan","year":"2015","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.berh.2023.101893_bib101","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O","article-title":"Damage in systemic lupus erythematosus and its association with corticosteroids","volume":"43","author":"Zonana-Nacach","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib102","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3899\/jrheum.190250","article-title":"Sj\u00f6gren syndrome in systemic lupus erythematosus: a subset characterized by a systemic inflammatory state","volume":"47","author":"Ruacho","year":"2020","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2023.101893_bib103","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3899\/jrheum.090804","article-title":"Secondary sj\u00f6gren\u2019s syndrome in systemic lupus erythematosus defines a distinct disease subset","volume":"37","author":"Baer","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101893_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2023.101893_bib105","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/acr.24849","article-title":"Evaluating the construct of damage in systemic lupus erythematosus","volume":"75","author":"Johnson","year":"2023","journal-title":"Arthritis Care Res"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T13:37:30Z","timestamp":1729172250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694223000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521694223000797"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2023.101893","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic lupus erythematosus and damage: What has changed over the past 20 years?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2023.101893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101893"}}